| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.97B | +12.1% |
| Cost of Revenue | $6.17B | -4.5% |
| Gross Profit | -$1.20B | +40.9% |
| R&D Expense | $1.61B | -19.1% |
| SG&A Expense | $1.88B | +9.5% |
| Operating Income | -$4.69B | +18.3% |
| Pre-tax Income | -$4.74B | +12.7% |
| Income Tax | $5.0M | +400.0% |
| Net Income | -$4.75B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.29B | -32.6% |
| Short-term Investments | $2.41B | +59.2% |
| Accounts Receivable | $443.0M | +175.2% |
| Inventory | $2.25B | -14.2% |
| Current Assets | $10.58B | -14.1% |
| Total Assets | $15.41B | -8.2% |
| Current Liabilities | $2.25B | -9.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.72B | +64.7% |
| Capital Expenditures | $1.14B | +11.2% |
| Investing Cash Flow | -$1.98B | +21.1% |
| Financing Cash Flow | $1.14B | -63.7% |
| Free Cash Flow | -$2.86B | +51.5% |
| +12.6% |
| EPS (Basic) | -$4.69 | +18.3% |
| EPS (Diluted) | -$4.69 | +18.3% |
| Long-term Debt |
| $4.44B |
| +0.2% |
| Total Liabilities | $8.85B | +15.9% |
| Stockholders' Equity | $6.56B | -28.2% |